The company's Bexxar product seems pretty effective in clinical trials.
Company is relatively cheap too.
Information posted in the discussion should not be considered to be coming from Prohost Research. Prohost is an independent publication providing information on biotech companies. Prohost does not accept compensation from companies that are featured or profiled. It is strongly recommended that any purchase or sale decisions to any of the featured companies be discussed with a financial advisor or broker prior to completing any such purchase or sale decision. All statements or expressions are the opinion of Prohost and are not meant to be a solicitation or recommendation to buy, sell, or hold securities.